Richard Ågren

Publications
CV
Public outreach and news

Articles

Article: TOXICS. 2023;11(12):959
Neuropathy with Cerebral Features Induced by Nitrous Oxide Abuse-A Case Report
Lindeman E; Melin S; Paucar M; Agren R
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2023;26(9):599-606
In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics
Agren R; Betari N; Saarinen M; Zeberg H; Svenningsson P; Sahlholm K
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(13):10924
An E280K Missense Variant in KCND3/Kv4.3-Case Report and Functional Characterization
Agren R; Geerdink N; Brunner HG; Paucar M; Kamsteeg E-J; Sahlholm K
Article: MOLECULAR BIOLOGY AND EVOLUTION. 2023;40(6):msad130
Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From Neandertals
Agren R; Patil S; Zhou X; FinnGen; Sahlholm K; Paabo S; Zeberg H
Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1087171
Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
Burstrom V; agren R; Betari N; Valle-Leon M; Garro-Martinez E; Ciruela F; Sahlholm K
Article: NEUROPSYCHOPHARMACOLOGY. 2022;47(13):2319-2329
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT_1A receptor agonist SEP-383856
Saarinen M; Mantas I; Flais I; Agren R; Sahlholm K; Millan MJ; Svenningsson P
Article: BIOSENSORS-BASEL. 2022;12(8):601
Fluorescence-Based Measurements of Membrane-Bound Angiotensin Converting Enzyme 2 Activity Using Xenopus Laevis Oocytes
Fast L; Agren R; Zeberg H
Article: BIOMEDICINES. 2021;10(1):22
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D₂ Receptor
agren R; Sahlholm K
Article: FASEB JOURNAL. 2021;35(11):e22013
G protein-coupled receptor kinase-2 confers isoform-specific calcium sensitivity to dopamine D₂ receptor desensitization
Agren R; Sahlholm K
Article: CHEMICAL SCIENCE. 2021;12(33):10990-11003
Mechanistic insights into dopaminergic and serotonergic neurotransmission - concerted interactions with helices 5 and 6 drive the functional outcome
Stepniewski TM; Mancini A; Agren R; Torrens-Fontanals M; Semache M; Bouvier M; Sahlholm K; Breton B; Selent J
Article: SCIENTIFIC REPORTS. 2021;11(1):13136
Worldwide antipsychotic drug search intensities: pharmacoepidemological estimations based on Google Trends data
Agren R
Article: FRONTIERS IN AGING NEUROSCIENCE. 2021;13:667854
Voxel-Based Morphometry of Cerebellar Lobules in Essential Tremor
Agren R; Awad A; Blomstedt P; Fytagoridis A
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(8):4078
Dopamine D₂ Receptor Agonist Binding Kinetics-Role of a Conserved Serine Residue
Agren R; Stepniewski TM; Zeberg H; Selent J; Sahlholm K
Article: NEUROLOGY-GENETICS. 2021;7(1):e546
V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations
Paucar M; Agren R; Li T; Lissmats S; Bergendal A; Weinberg J; Nilsson D; Savichetva I; Sahlholm K; Nilsson J; Svenningsson P
Article: JOURNAL OF NEUROSCIENCE METHODS. 2021;348:108984
Low-Resistance silver bromide electrodes for recording fast ion channel kinetics under voltage clamp conditions
Agren R; Zeberg H
Article: FRONTIERS IN PHARMACOLOGY. 2020;11:581151
Voltage-Dependent Dopamine Potency at D₁-Like Dopamine Receptors
Agren R; Sahlholm K
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(19):3130-3143
Ligand with Two Modes of Interaction with the Dopamine D₂ Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism
Agren R; Zeberg H; Stepniewski TM; Free RB; Reilly SW; Luedtke RR; Arhem P; Ciruela F; Sibley DR; Mach RH; Selent J; Nilsson J; Sahlholm K
Article: STEREOTACTIC AND FUNCTIONAL NEUROSURGERY. 2020;98(5):331-336
Pulse Width and Implantable Pulse Generator Longevity in Pallidal Deep Brain Stimulation for Dystonia: A Population-Based Comparative Effectiveness Study
Agren R; Bartek JJ; Johansson A; Blomstedt P; Fytagoridis A
Article: SCIENTIFIC REPORTS. 2019;9(1):8175
Closed and open state dependent block of potassium channels cause opposing effects on excitability - a computational approach
Agren R; Nilsson J; Arhem P
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2018;21(12):1102-1108
The Beta-Arrestin-Biased Dopamine D₂ Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation
Agren R; Arhem P; Nilsson J; Sahlholm K
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2018;496(1):101-104
Point mutation of a conserved aspartate, D69, in the muscarinic M₂ receptor does not modify voltage-sensitive agonist potency
Agren R; Sahlholm K; Nilsson J; Arhem P
Show more

Employments

Assistant Professor, Department of Physiology and Pharmacology, Karolinska Institutet, 2024-2030
Postdoctoral Researcher, Department of Physiology and Pharmacology, Karolinska Institutet, 2023-2024

Articles

Employments

News from KI

Events from KI